We have to admit that this is the first analysis of polymorphisms in the MDM2 and MDM4 genes in relation to the breast cancer clinical characteristics in Lithuania; consequently, a much larger cohort of breast cancer patients would be required to verify our findings. Here, MDM4 is linked to breast carcinoma.